Moderna
MRNA
#276
Rank
S$107.53 B
Marketcap
S$265.77
Share price
3.43%
Change (1 day)
741.63%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -S$3.92 Billion

According to Moderna 's latest financial reports the company's current earnings are S$2.21 Billion. In 2025 the company made an earning of -S$3.56 Billion, an increase over its 2024 earnings that were of -S$4.62 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$3.92 Billion10.23%
2025 -S$3.56 Billion-23.03%
2024 -S$4.62 Billion-8.22%
2023 -S$5.04 Billion-140.65%
2022 S$12.38 B-27.81%
2021 S$17.14 B-1911.15%
2020 -S$0.95 Billion44.7%
2019 -S$0.66 Billion28.63%
2018 -S$0.51 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$24.13 B-714.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$16.29 B-515.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
S$8.66 B-320.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-S$61.15 Million-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.16 Billion-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-S$53.84 Million-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.57 B-140.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-S$0.21 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA